Clinical Trials in Boston

Showing 8741-8760 of 17,836 trials

A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT01254409

The aims of the study are to assess safety, tolerability, the pharmacokinetic profile, and the pharmacodynamic profile of multiple doses of PRM-151 administered IV to IPF patients.

Idiopathic Pulmonary Fibrosis

Hoffmann-La Roche21 participantsStarted Mar 2011

Boston, Massachusetts, United States • Durham, North Carolina, United States • Leiden, Netherlands

COMPLETEDPhase 3< 1 mile

A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

NCT01721746

The purpose of the study is to estimate the response rate and compare overall survival of patients taking BMS-936558 to those taking study physician's choice of either Dacarbazine or Carboplatin and Paclitaxel

Unresectable or Metastatic Melanoma

Bristol-Myers Squibb405 participantsStarted Dec 2012

Phoenix, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +92 more locations

A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

Find Trials by Condition in Boston

Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

Inhaled Nitric Oxide for Preventing Progression in COVID-19

An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Supported Employment Demonstration

Study to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis

Study to Evaluate Safety and Efficacy of GrafixPL for the Treatment of Venous Leg Ulcers

A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes

Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status

The Product Surveillance Registry REVERSE Post Approval Study

LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)

Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome

SMS Maama Project COVID-19

Revealed Versus Concealed Cerebroplacental Ratio